Wuhan National Bio-industry Base, also known as the Biolake, is China's second largest state-level biotech industrial base in view of overall strength, in Wuhan East Lake High-tech Development Zone – also known as the Optics Valley of China – located in China's Central Hubei province.

[Photo/wehdz.gov.cn]

The construction of the Biolake in the city of Wuhan started in November 2008 and after 11 years of development the bioindustry has become one of the pillar industries of Optics Valley. 

At present, Biolake's seven industrial parks have formed an industrial cluster characterized by biomedicines, bio medical engineering, bio agriculture, precision medicine, smart medicines and bio services.

Biolake in OVC is one of China's key new medicine research centers. It is also a national innovative medicine incubator, and national genetic engineering drug public service platform. 

Biolake hosts over 3,000 biotech companies, including eight Fortune Global 500 firms, 28 board-listed companies, and 27 companies listed on the New Third Board. It has attracted 31 academicians, 34 national high-level talents, and 92 provincial high-level talents, with 779 teams under the "3551 Optics Valley Talent Plan". In the national ranking by the China National Center for Biotechnology Development, Biolake's biotech industry ranked fourth in overall strength.

Meanwhile, firms dealing with smart medical services also thrive in Biolake, covering wearable devices, remote medical services, health big data integration, health managing consultation, and software and APP development.

[Photo/wehdz.gov.cn]